Introduction {#sec1}
============

Critically ill patients frequently experience pain during their stay in the intensive care unit (ICU). Nearly 30% of ICU patients suffer from pain at rest and up to 50% suffer pain during nursing procedures \[[@cit0001]\]. Acute pain experienced in the ICU may become a chronic problem after discharge from the unit, as a lifelong ICU footprint. Everyday nursing procedures and interventions (i.e. positioning, mouth and trachea suctioning, wound care, catheter removal or placement, cannulation or intubation) may be a potential source of pain; therefore there is a clinical need for a simple and easy ICU pain scale available in every language to evaluate this condition in patients unable to self-report pain.

Assessment of pain in patients treated in the ICU is a daily clinical challenge. Various guidelines regarding assessment of pain, agitation and delirium in critically ill patients (PAD guidelines from the year 2013, DAS guidelines from 2015) and recommendations (eCASH from 2016) exist to guide the ICU care team in the process of pain evaluation and management \[[@cit0002]--[@cit0004]\]. The area of pain monitoring is traditionally the weakest part of the PAD Guidelines in terms of data on the tools. That is because this particular element of suffering is very subjective and the resultant intra-class correlation coefficient (ICC) is generally lower than barometers of reliability and validity for agitation/arousal and delirium instruments \[[@cit0002]\].

The gold standard for pain assessment is the patient's self-report of pain using the Numeric Rating Scale (NRS) or Visual Analog Scale (VAS), which can be aided with behavioural scales only when the self-report is impossible to obtain. Changes in vital signs (heart rate, blood pressure or respiratory rate) are not reliable measures for pain as their fluctuations may either be associated with the underlying pathology or may represent the side effects of suffering. The observational pain scales include the Critical-Care Pain Observation Tool (CPOT) and the Behavioural Pain Scale (BPS) and have been recommended and validated for clinical use in critically ill adults \[[@cit0005], [@cit0006]\]. However, their validation in a given patient population (cardiac, burn, different languages) is strongly recommended and required. It has been shown that implementation of systematic pain assessment, including evaluation by the medical team (doctors, nurses, physiotherapists) as well as family members, to identify pain-related behaviour aids better identification of patients' needs \[[@cit0005]\].

It is clear therefore why effective pain management has been identified as one of the first priorities in a humanized ICU approach, but there is still room for improvement in this area. The above-mentioned pain scales have not been officially translated into Polish or validated in Poland. The need to equip critical care teams with dedicated monitoring tools is clear, as is the understanding that early identification of pain warrants early and adequate treatment. The CPOT has been developed by ICU professionals, yet it has not been translated or validated in Polish until now. The aim of this study was to validate the CPOT translated into Polish using inter-rater reliability, discriminant validity and criterion validity.

Material and methods {#sec2}
====================

CPOT translation {#sec2.1}
----------------

For the purpose of this study and further use, the CPOT was translated from English into Polish and received a back-translation after written permission was obtained from the author (C. Gelinas). The Polish CPOT translation was published and is available for general use \[[@cit0007]\]. Next, official permission was granted by the American Association of Critical Care Nurses to use the translated scale. This step was followed by a period of intensive theoretical and bedside training regarding the CPOT that led to this study.

The Polish version of the CPOT is a direct translation of the English version. To verify the linguistic accuracy of the translation it was back-translated and evaluated by an English-speaking research team from Vanderbilt University on behalf of the first author of the original study. The CPOT includes four behavioural domains and was designed to specifically detect pain in critically ill adults. The four categories are: facial expressions, body movements, muscle tension and either compliance with the ventilator (for patients who are intubated) or verbalisation (for patients who are extubated). In each category a score of 0, 1 or 2 can be assigned to a total of between 0 and 8 points. There are no specific differences in the Polish version as compared to the English version of the CPOT.

Study population {#sec2.2}
----------------

A prospective observational cohort study was performed including 71 eligible intubated adult patients at the 17-bed Intensive Care Unit of the Department of Anaesthesiology, Intensive Therapy and Acute Intoxications of the tertiary teaching hospital (Teaching Hospital No. 2) of the Pomeranian Medical University in Szczecin, Poland between December 2016 and March 2017. The unit has implemented a no-hypnotic analgesia-based protocol (fentanyl and morphine intravenous infusion) for intubated patients. The opioid-based analgosedation regime was aided with non-opioid analgesics (metamizole, paracetamol) and adjuvants (lignocaine) as this has been shown to act as an opioid-sparing approach.

Ethical concerns {#sec2.3}
----------------

This observational study was presented to the Bioethical Committee of the Pomeranian Medical University on 21.12.2016 and the requirement for written informed consent was waived because of the non-interventional character of this study. Pain was assessed during routine everyday nursing procedures such as changing patient position and eye wiping -- both regarded as ICU daily care. Also patient self-reporting of pain was part of routine care by the bed-side nurses in our ICU. All patients admitted to the ICU were evaluated by two members of the study team based on the inclusion and exclusion criteria and re-evaluated by the main investigator.

Inclusion criteria {#sec2.4}
------------------

-   Age above 18 years,

-   Ability to communicate in the Polish language,

-   Intubated or with tracheostomy for more than 48 h before inclusion with or without mechanical ventilation (controlled modes, spontaneous modes),

-   Richmond Agitation Sedation Scale (RASS) score above or equal to --3,

-   Unrestricted sight and hearing,

-   No limitations for body position changing,

-   With no important intervention within the last 48 h prior to inclusion in the study (i.e. operation, tracheostomy).

Exclusion criteria {#sec2.5}
------------------

-   A medical need for deep sedation -- treatment of severe respiratory failure associated with patient-ventilator dyssynchrony, preventing awareness during neuromuscular blockade, status epilepticus, certain surgical conditions requiring immobility, cases of severe brain injury with intracranial hypertension,

-   Facial trauma (unable to evaluate facial expression),

-   RASS --4 or --5,

-   Neurological or psychiatric disorders,

-   Use of neuromuscular blocking agents,

-   Regular narcotic users,

-   Chronic pain syndrome patients.

Study measures {#sec2.6}
--------------

Each assessment was performed by two members of the study team, who obtained both theoretical and practical training from the primary investigator (PI)/first author (KK). To provide multiple inter-rater variability opportunities the evaluation was performed by different healthcare providers (rater A and rater B), rater A always being the PI (physician, ICU consultant) and rater B being one of 3 ICU physicians (1 ICU consultant, 2 senior ICU residents), 4 senior ICU nurses or 1 ICU physiotherapist. The CPOT was evaluated concomitantly by two raters blinded to each other and patient assessment was performed once a day, during daytime hours. Pain intensity was evaluated during routine nursing procedures in the ICU, both non-nociceptive procedures (NNP) -- eyelid wiping with normal saline -- and nociceptive procedures (NP) -- patients' positioning and turning.

The assessments were performed at fixed time points: 5 min prior to the procedure, during the procedure and 15 min after the procedure. Each assessment included NRS self-report by the patient (if possible) and CPOT assessment carried out by two observers blinded to each other. As two types of procedures were performed, a total of 6 assessments was obtained from each rater. Altogether the time points were as follows: series I -- non-nociceptive -- T1 (5 min before NNP), T2 (at NNP), T3 (15 min after NNP); and series II -- nociceptive -- T4 (5 min before NP), T5 (at NP), T6 (15 min after NP).

Basic demographic data collected include: sex, age, APACHE II (Acute Physiology and Chronic Health Evaluation II) score within 24 h of admission, admission source (internal medicine vs surgery), data regarding mechanical ventilation of intubated patients, type of mechanical ventilation -- controlled modes (BIPAP, SIMV) or spontaneous modes (CPAP) -- and use of co-analgesics during the 24 h prior to study inclusion. The level of consciousness and arousal was assessed using the Polish version of the Richmond Agitation Sedation Scale (RASS), ranging from --5 (no reaction to voice or touch) to +4 (combative), whereas target RASS was 0 (calm, cooperative patient). The ICU delirium screening was performed using the Polish version of Confusion Assessment Method for ICU (CAM-ICU). Both sedation and delirium assessment was performed prior to CPOT evaluation.

The patient's self-report was initiated by the bed-side nurse taking care of the patient with a question -- Do you feel pain? -- a NO answer was regarded as equivalent to NRS of 0, whereas a YES answer led to NRS assessment using a pre-printed large scale for the patient to show the number from 0 (no pain) to 10 (the worst pain ever). The CPOT was developed as means of pain assessment in critically ill patients and covers 4 behavioural categories -- facial expression, body movement, ventilator synchrony and muscle tone. In each category the raters can appoint from 0 to 2 points, up to a total amount of 0 to 8 points.

This prospective observational cohort study was registered at ClinicalTrials.gov website and received the following identifier: NCT03024528.

Statistical analysis {#sec2.7}
--------------------

Baseline characteristics of the study group were analysed using descriptive statistics and were presented with either mean ± SD for quantitative parameters and numbers and percentages for qualitative parameters. To assess the psychometric properties of the CPOT, a methodology consistent with previously reported studies was applied \[[@cit0005], [@cit0008], [@cit0009]\]. Inter-rater reliability was calculated using intraclass correlation coefficients (ICC 3.1) for the CPOT. Based on previous studies the sample size required for validating CPOT established using precision ICC (3.1) was estimated to be between 55 and 65 patients (precision of ICC of 0.85 ±0.10, for a scale with four subscales) \[[@cit0005]\]. In order to test the criterion validity of the CPOT we performed receiver operating characteristic (ROC) curve analysis and determined the cut-off value for optimal sensitivity and specificity for the detection of the patient's self-reported pain. Criterion validity was tested by Spearman's rank correlation coefficient (Rs) between CPOT and NRS scales. The Rs was also used to analyse correlations between CPOT scores and physiological indicators. We used the Wilcoxon signed-rank test for discriminant validity assessment by comparison of CPOT values between time points. Statistical significance was set at *p* \< 0.05. Statistical analysis was performed using Excel (Microsoft) and Statistica 13 with Medical Bundle 4.0 (StatSoft Inc.).

Results {#sec3}
=======

Baseline descriptive statistics {#sec3.1}
-------------------------------

To perform this prospective cohort study we screened 99 patients for eligibility, yet 28 were excluded (15 required deep sedation due to patient-ventilator asynchrony, 4 required an emergency operation or re-operation, 4 -- chronic pain syndromes, 3 -- psychiatric reasons, 1 -- surgical immobility, 1 -- deep sedation due to status epilepticus). A total of 71 patients were included in the study (mean age: 65.7 ±12.2), predominantly males (70.42%, 50/71) with a mean APACHE II score 24 h within admission to the ICU of 26.0 ±10.6. The majority of the patients were admitted from a surgical unit (61.97%, 44/71), on CPAP (70.42%, 50/71) and screened positive for ICU delirium (CAM-ICU positive) -- 53.52% (38/71). None of the patients received a sedative agent at the time of assessment and 35.22% (25/71) received no opioid infusion. Of the remaining 64.78% (46/71) of patients receiving an opioid infusion, 49.29% (35/71) received intravenous fentanyl infusion and 15.49% (11/71) received intravenous morphine infusion. The use of co-analgesics was recorded as follows: none -- 45.07% (32/71); paracetamol -- 26.76% (19/71); metamizole (dipyrone) -- 29.58% (21/71); and lignocaine -- 4.23% (3/71). All the baseline data are depicted in [Table I](#t0001){ref-type="table"}.

###### 

Baseline characteristics of study group

  Variable                                              Value (*n* = 71)
  ----------------------------------------------------- ------------------
  Age, mean ± SD \[years\]                              65.7 ±12.2
  Gender, *n* (%):                                      
   Female                                               21 (29.58)
   Male                                                 50 (70.42)
  APACHE II score within 24 h of admission, mean ± SD   26.0 ±10.6
  Admission to ICU, *n* (%):                            
   Surgical                                             44 (61.97)
   Medical                                              27 (38.03)
  Mode of ventilation, *n* (%):                         
   SIMV                                                 12 (16.90)
   BIPAP                                                9 (12.68)
   CPAP                                                 50 (70.42)
  Analgesia -- opioids, *n* (%):                        
   None                                                 25 (35.22)
   Fentanyl                                             35 (49.29)
   Morphine                                             11 (15.49)
  Co-analgesia -- non-opioid analgesics, *n* (%):       
   None                                                 32 (45.07)
   Paracetamol                                          19 (26.76)
   Metamizole                                           21 (29.58)
   Lignocaine                                           3 (4.23)
  CAM-ICU, *n* (%):                                     
   Positive -- ICU delirium present                     38 (53.52)
   Negative -- ICU delirium absent                      33 (46.48)

ICU -- intensive care unit, CAM-ICU -- Confusion Assessment Method for ICU, n -- number of patients.

The distribution of the NRS for patients' self-reported pain (where available) and CPOT values for rater A and rater B at each assessment time (T1--T6) is shown in [Table II](#t0002){ref-type="table"}.

###### 

Distribution of the values for patients' self-reported pain (NRS available in 58 patients), rater A and rater B CPOT assessment at each measured time

  Assessment   Time   NRS self-report (mean ± SD)   CPOT rater A (mean ± SD)   CPOT rater B (mean ± SD)
  ------------ ------ ----------------------------- -------------------------- --------------------------
  Before NNP   T1     0.55 ±1.14                    0.76 ±1.26                 0.73 ±1.18
  NNP          T2     0.64 ±1.13                    0.83 ±1.26                 0.79 ±1.26
  After NNP    T3     0.52 ±0.98                    0.70 ±1.21                 0.70 ±1.25
  Before NP    T4     0.55 ±1.07                    0.70 ±1.22                 0.72 ±1.23
  NP           T5     2.84 ±1.98                    3.18 ±1.88                 3.15 ±1.93
  After NP     T6     0.74 ±1.13                    0.96 ±1.31                 0.92 ±1.27

NRS -- Numeric Rating Scale, NNP -- non-nociceptive procedure, NP -- nociceptive procedure.

Inter-rater reliability for Polish CPOT {#sec3.2}
---------------------------------------

The intraclass correlation coefficients (ICC) for rater A and rater B scored \> 0.85 at each measured time point ([Table III](#t0003){ref-type="table"}), i.e. at rest (T1, T3, T4, T6), at the non-nociceptive procedure (T2) and at the nociceptive procedure (T5). High intraclass correlation coefficients confirmed inter-rater reliability of the Polish version of the CPOT.

###### 

Distribution of ICC for rater A vs. rater B at each measured assessment

  Assessment   Time   ICC: rater A/rater B
  ------------ ------ ----------------------
  Before NNP   T1     0.972
  NNP          T2     0.987
  After NNP    T3     0.972
  Before NP    T4     0.995
  NP           T5     0.973
  After NP     T6     0.979

ICC -- intra-class correlation coefficient, NNP -- non-nociceptive procedure, NP -- nociceptive procedure.

Criterion validity for Polish CPOT {#sec3.3}
----------------------------------

Data in [Table IV](#t0004){ref-type="table"} show a very strong correlation between pain self-reported by the patient using the NRS at T1, T2 and T5 and pain assessed by both rater A and rater B using the CPOT (*Rs* \> 0.85, *p* \< 0.0001)*.* The results of the NRS were available for 58/71, meaning that 81.7% of patients were able to self-report pain using the NRS. [Figure 1](#f0001){ref-type="fig"} shows scatterplots depicting strong correlations between NRS results and CPOT evaluated by rater A and rater B at T5 (nociceptive procedure).

###### 

Spearman rank correlation coefficients for correlations between Critical Care Pain Observation Tool (CPOT) and self-reported pain (NRS) values for 2 raters at 3 time points, *n* = 58

  Assessment   Time   NRS--CPOT correlation rater A            NRS--CPOT correlation rater B
  ------------ ------ ---------------------------------------- ----------------------------------------
  Before NNP   T1     0.882[\*](#tf4-1){ref-type="table-fn"}   0.873[\*](#tf4-1){ref-type="table-fn"}
  NNP          T2     0.873[\*](#tf4-1){ref-type="table-fn"}   0.852[\*](#tf4-1){ref-type="table-fn"}
  NP           T5     0.885[\*](#tf4-1){ref-type="table-fn"}   0.892[\*](#tf4-1){ref-type="table-fn"}

p \< 0.0001. NNP -- non-nociceptive procedure, NP -- nociceptive procedure.

![Scatterplot for correlation between NRS and CPOT reported at T5 by rater A (T5A) and rater B (T5B)](AMS-14-30499-g001){#f0001}

The ROC for Polish version of CPOT {#sec3.4}
----------------------------------

The values for sensitivity and specificity of the Polish version of the CPOT for different cut-off values are shown in [Table V](#t0005){ref-type="table"}.

###### 

Sensitivity and specificity for CPOT cut-off values to detect patients' self-reported pain at nociceptive procedure (T5)

  CPOT   Sensitivity rater A (%)   Specificity rater A (%)   Correctly classified rater A (%)   Sensitivity rater B (%)   Specificity rater B (%)   Correctly classified rater B (%)
  ------ ------------------------- ------------------------- ---------------------------------- ------------------------- ------------------------- ----------------------------------
  ≥ 1    100                       30                        87.9                               100                       30                        87.9
  ≥ 2    91.7                      80                        89.7                               91.7                      90                        91.4
  ≥ 3    66.7                      100                       72.4                               60.4                      100                       67.2
  ≥ 4    39.6                      100                       50                                 41.7                      100                       51.7
  ≥ 5    22.9                      100                       36.2                               20.8                      100                       34.5
  ≥ 6    10.4                      100                       25.9                               12.5                      100                       27.6

CPOT -- Critical Care Pain Observation Tool.

The area under the curve (AUC) values for the CPOT to detect pain for all given assessment times are shown in [Table VI](#t0006){ref-type="table"}. No significant differences between raters A and B were found.

###### 

ROC AUC for CPOT assessments performed by rater A and rater B to detect patients' self-reported pain

  Assessment   Time   AUC Rater A   AUC Rater B   *P*-value
  ------------ ------ ------------- ------------- -----------
  Before NNP   T1     0.978         0.974         0.79
  NNP          T2     0.950         0.926         0.48
  After NNP    T3     0.933         0.948         0.18
  Before NP    T4     0.912         0.916         0.53
  NP           T5     0.938         0.951         0.89
  After NP     T6     0.918         0.869         0.13

AUC -- area under the ROC curve, NNP -- non-nociceptive procedure, NP -- nociceptive procedure, p -- statistical significance for difference between AUC of rater A and B.

Both sensitivity and specificity for the Polish version of the CPOT are high for each study period -- T1, T2 and T5 -- for both rater A and rater B, as depicted in [Figure 2](#f0002){ref-type="fig"}. The receiver operating characteristic curves (ROC) at T1, T2 and T5 for both raters are shown in [Figures 3](#f0003){ref-type="fig"}--[5](#f0005){ref-type="fig"}.

![Sensitivity and specificity for CPOT at nociceptive procedure (T5) for rater A (T5A) and rater B (T5B) -- the proposed cut-off value for CPOT is set at 2](AMS-14-30499-g002){#f0002}

![Receiver operating characteristic curves (ROC) at rest (T1) for rater A (AUC = 0.978) and rater B (AUC = 0.974)](AMS-14-30499-g003){#f0003}

![Receiver operating characteristic curves (ROC) during non-nociceptive procedure (T2) for rater A (AUC = 0.950) and rater B (AUC = 0.926)](AMS-14-30499-g004){#f0004}

![Receiver operating characteristic curves (ROC) during nociceptive procedure (T5) for rater A (AUC = 0.938) and rater B (AUC = 0.951)](AMS-14-30499-g005){#f0005}

The ROC curve at rest ([Figure 3](#f0003){ref-type="fig"}), at non-nociceptive procedure ([Figure 4](#f0004){ref-type="fig"}) and nociceptive procedure ([Figure 5](#f0005){ref-type="fig"}).

Discriminant validity for Polish CPOT {#sec3.5}
-------------------------------------

The discriminant validity for the Polish version of the CPOT was also high. [Table VII](#t0007){ref-type="table"} shows CPOT ranges at specified observation times for rater A and rater B. Both methods, NRS and CPOT, show higher scores during pain than at rest or during non-nociceptive procedures, as shown in [Figures 6](#f0006){ref-type="fig"}--[8](#f0008){ref-type="fig"}.

###### 

Comparison of Critical Care Pain Observation Tool (CPOT) values between time points for raters A and B

  Assessment         Time       CPOT rater A                            CPOT rater B
  ------------------ ---------- --------------------------------------- ---------------------------------------
  Before NNP-NNP     T1 to T2   1.4                                     0.97
  NNP -- After NNP   T2 to T3   2.29\*                                  1.47
  Before NP-NP       T4 to T5   7.06[\*](#tf7-1){ref-type="table-fn"}   7.00[\*](#tf7-1){ref-type="table-fn"}
  NP-After NP        T5 to T6   7.00[\*](#tf7-1){ref-type="table-fn"}   6.90[\*](#tf7-1){ref-type="table-fn"}
  NNP-NP             T2 to T5   7.11[\*](#tf7-1){ref-type="table-fn"}   7.06[\*](#tf7-1){ref-type="table-fn"}

Results of a Wilcoxon signed-rank test.

p \< 0.001. NNP -- non-nociceptive procedure, NP -- nociceptive procedure.

![Mean CPOT values (± SD) reported by rater A at time points T1--T6; CPOT values at T5 were significantly higher that at other time points; p \< 0.001](AMS-14-30499-g006){#f0006}

![Mean CPOT values (± SD) reported by rater B at time points T1--T6; CPOT values at T5 were significantly higher that at other time points; p \< 0.001](AMS-14-30499-g007){#f0007}

![Mean NRS values (± SD) reported by th patient at time points T1--T6; CPOT values at T5 were significantly higher that at other time points; p \< 0.001](AMS-14-30499-g008){#f0008}

[Table VII](#t0007){ref-type="table"} and [Figures 6](#f0006){ref-type="fig"}--[8](#f0008){ref-type="fig"} show that both methods, NRS and CPOT, show higher scores during nociceptive procedures (T5) than at rest (T4, T6) or during non-nociceptive procedures (T1--T3); the results are statistically significant.

Correlation between CPOT and physiological parameters {#sec3.6}
-----------------------------------------------------

[Table VIII](#t0008){ref-type="table"} shows Spearman's rank correlation coefficients for the CPOT and vital signs (HR, systolic, diastolic and mean arterial pressure). A negative correlation means that higher CPOT values correspond to lower vital signs. Statistical significance was found only for negative correlation of diastolic blood pressure and CPOT at rest (T1), at the non-nociceptive procedure (T2) and during the nociceptive procedure (T5), for both raters (A and B). No correlation was found between CPOT scores and physiological indicators, apart from diastolic blood pressure.

###### 

Spearman rank correlation coefficients for correlations between Critical Care Pain Observation Tool (CPOT) and physiological indicators values for 2 raters at 3 time points

  Assessment    Time   Heart rate   Systolic BP   Diastolic BP                              Mean BP
  ------------- ------ ------------ ------------- ----------------------------------------- -----------------------------------------
  Rater A:                                                                                  
   Before NNP   T1     0.18         --0.02        --0.27[\*](#tf8-1){ref-type="table-fn"}   --0.18
   NNP          T2     0.19         --0.10        --0.32[\*](#tf8-1){ref-type="table-fn"}   --0.24[\*](#tf8-1){ref-type="table-fn"}
   NP           T5     0.23         --0.10        --0.28[\*](#tf8-1){ref-type="table-fn"}   --0.20
  Rater B:                                                                                  
   Before NNP   T1     0.22         --0.01        --0.27[\*](#tf8-1){ref-type="table-fn"}   --0.17
   NNP          T2     0.16         --0.09        --0.30[\*](#tf8-1){ref-type="table-fn"}   --0.23
   NP           T5     0.18         --0.08        --0.28[\*](#tf8-1){ref-type="table-fn"}   --0.19

p \< 0.05. BP -- blood pressure, NNP -- non-nociceptive procedure, NP -- nociceptive procedure.

Discussion {#sec4}
==========

The POL-CPOT study has validated the Polish version of the Critical Care Pain Observation Tool, introducing this assessment tool to ICUs in Poland. This is one of the steps in improving quality of care and patient outcome, as defined by international guidelines \[[@cit0002]--[@cit0004]\]. Clinical observation and the results of prospective clinical trials show that the incidence of pain in critically ill, intubated, mechanically ventilated patients is underreported and untreated. Part of the problem lies in the fact that behavioural pain assessment tools were originally developed and available only in English or French. Because a behavioural pain scale was unavailable for critical care patients in Poland we undertook a process of translation of the CPOT and BPS into Polish \[[@cit0007]\]. Afterwards we performed this observational study to validate the Polish version of the CPOT to make it available to Polish-speaking populations world-wide. The results of this study add the Polish version to the recently translated and validated Danish and Chinese CPOT scales \[[@cit0008]--[@cit0010]\].

Our study included unsedated patients who received no hypnotic, only analgesia, namely morphine or fentanyl as an intravenous infusion, to tolerate intubation and mechanical ventilation. This approach to ICU treatment is quite unique as it allows the patients to be awake and cooperative. Therefore the majority of patients (58/71, 81.7%) were able to self-report pain using the NRS scale. Opioid delivery in this study differs from that recommended by the guidelines, i.e. intermittent boluses -- as it was an observational study we did not want to change current practice on our ICU. Continuous opioid infusion is used in our unit as it is a good balance between patient comfort and the available resources, i.e. a limited nurse-to-patient ratio.

The Polish version of the CPOT showed very good inter-rater reliability, with ICC above 0.9 for all time points. This is especially important as the CPOT was performed by 9 different observers -- rater A was the primary investigator and rater B was one out of 8 persons from the study team. We set this goal in contrast to other researchers who only used two observers as CPOT raters at all assessments and reported it as a major limitation to their study \[[@cit0008]\]. Also Gelinas *et al.* in the original CPOT validation study, where only two raters collected the data, underlined the importance of using more raters in the evaluation of inter-rater reliability \[[@cit0005]\]. Therefore it is especially important in the POL-CPOT study that participation of multiple assessors did not lower the inter-rater reliability scores. It must be underlined that pain monitoring is traditionally the weakest part of the PAD or DAS Guidelines regarding the available data on the tools. Therefore our study showed that this subjective element of suffering had good resultant ICC coefficients.

Strong correlations (*Rs* \> 0.85) between patients' self-report of pain intensity at rest measured by the NRS and the CPOT score showed criterion validity (*p* \< 0.0001). This makes it a reliable tool, especially in the context of other validation studies \[[@cit0008], [@cit0011]--[@cit0013]\]. The original results reported by Gélinas *et al.* showed that the CPOT has good internal consistency determined by standardized Cronbach's α (α = 0.89) with good agreement percentages (80%) and acceptable inter-rater reliability (κ = 0.52--1; ICC = 0.80--0.93) \[[@cit0014], [@cit0015]\]. On the other hand, the study by Nürnberg *et al.* validating the Swedish version of the CPOT showed poor inter-rater reliability with a low-weighted κ coefficient (κ = 0.26) \[[@cit0012]\].

Discriminant validation was determined by higher CPOT scores during painful procedures as compared with non-painful procedures or assessment at rest (*p \<* 0.0001). This is consistent with other CPOT validation studies reporting significantly higher scores during nociceptive procedures than at rest or during non-nociceptive procedures \[[@cit0012], [@cit0016], [@cit0017]\]. One of the steps was to determine the cut-off values for the Polish version of the CPOT, which was based on a comparison of patients' self-report of presence of pain with the CPOT. Our study shows that the optimal cut-off point for POL-CPOT to detect pain at the nociceptive procedure is ≥ 2. According to Gelinas and Johnson, the cut-off point for the CPOT lies between 2 and 3 points, where a score of 2 is equivalent to pain \[[@cit0014]\]. The Danish CPOT validation study showed that cut-off values ≥ 3 and ≥ 4 for all included patients were equally good \[[@cit0008]\]. Multiple other studies have shown optimal cut-off values at \> 2 \[[@cit0015], [@cit0018]\]. In many countries translations of the CPOT were performed to aid ICU clinicians and validation studies showed its good consistency and validation \[[@cit0008]--[@cit0010], [@cit0019], [@cit0020]\].

It is also worth underlining that country-specific differences in pain detection and treatment exist. Interestingly, research shows that nationality-specific differences exist in terms of pain experience. Golicki and Niewada reported that Polish patients present with generally poorer health, especially when regarding the perception of pain \[[@cit0021]\]. Moreover, the study performed by Mędrzycka-Dąbrowska *et al.* in 2016 showed that pain management in Poland is still sub-optimal, especially in the elderly population \[[@cit0022]\]. Therefore adding a validated tool for pain assessment available in the Polish language seems valuable for healthcare professionals in Poland.

Study limitations must also be addressed. We did not assess the Cronbach coefficient as each subquestion in the CPOT scale was validated in previous studies \[[@cit0005], [@cit0011], [@cit0023]\]. We collected and analysed the data regarding vital signs both during the nociceptive and non-nociceptive procedures (NP and NNP), although many studies have shown that neither the heart rate nor blood pressure nor respiratory rate is a reliable index for pain in critically ill patients. It has been reported by other authors that vital signs are unreliable signs of pain and may be related to other conditions. No chronic pain syndrome patients or regular narcotic users were included in this study as these conditions are well-known confounding factors. In these conditions the sensitivity to pain increases and it may lead to abnormally high NRS or CPOT scores; therefore to have a clear picture for tool validation purposes these patients were excluded. It must be admitted however that future studies must report pain assessment also in chronic pain patients as their suffering seems to be pronounced in acute pain situations. It should also be underlined that the population studied by us was mainly composed of adult males. Considering that adolescents, children and females may have different thresholds for recognition of pain, one should bear in mind the value of the Polish CPOT in assessing pain in the other populations which have not been studied here. Further research might be required to validate this tool in other populations.

In conclusion, the findings of this study confirm that the Polish version of the Critical Care Pain Observation Tool can be regarded as a valid instrument for assessing pain among critically ill intubated adult patients. This tool is useful and reliable in critically ill patients with a no-hypnotic, opioid-infusion based analgo-sedation protocol. Polish CPOT scores correlated well with patients' self-reported presence of pain and showed excellent inter-rater reliability. This makes the Polish version of the CPOT a reliable pain assessment tool.
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